Protalix BioTherapeutics (PLX) Operating Income Growth (3y) (2013 - 2026)
Protalix BioTherapeutics (PLX) Operating Income Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Op. Inc Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
-1,580.97% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-29.67% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
16.35% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-50.81% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
13.47% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Protalix BioTherapeutics |
176.47 Mn |
165.67 Mn |
29.62 Mn |
119.66% |
| Date | Value |
|---|
| Mar 31, 2026 |
119.66% |
| Dec 31, 2025 |
-26.93% |
| Sep 30, 2025 |
38.94% |
| Jun 30, 2025 |
30.30% |
| Mar 31, 2025 |
-30.39% |
| Dec 31, 2024 |
48.33% |
| Sep 30, 2024 |
60.28% |
| Jun 30, 2024 |
35.79% |
| Mar 31, 2024 |
-9.44% |
| Dec 31, 2023 |
-58.45% |
| Sep 30, 2023 |
9.92% |
| Jun 30, 2023 |
123.18% |
| Mar 31, 2023 |
-36.15% |
| Dec 31, 2022 |
50.48% |
| Sep 30, 2022 |
-26.49% |
| Jun 30, 2022 |
1.83% |
| Mar 31, 2022 |
30.35% |
| Dec 31, 2021 |
-15.83% |
| Sep 30, 2021 |
20.43% |
| Jun 30, 2021 |
-10.77% |
